Lupus Clinical Trial Results

Browse clinical trials for Lupus by phase, sponsor and reported results. Data from ClinicalTrials.gov.

• Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-33444
  Phase 1/2 · Viatris Innovation GmbH · Completed · Feb 26, 2020
• Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupu
  Phase 2 · Viatris Innovation GmbH · Completed · Sep 22, 2023
• A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV
  Phase 3 · Hoffmann-La Roche · Active, not recruiting · Nov 6, 2025
• Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Condit
  N/A · Duke University · Completed · Jul 28, 2025
• Reducing Disparities in Medication Adherence in SLE
  N/A · Duke University · Completed · Jul 27, 2021
• Using the Cholinergic Anti-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain
  N/A · Northwell Health · Completed · Jul 8, 2026
• COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
  Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID) · Terminated · Aug 22, 2025
• Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis
  Phase 1 · Biocon Limited · Completed · Apr 18, 2025
• A Study of DS-7011a in Patients With Systemic Lupus Erythematosus
  Phase 1/2 · Daiichi Sankyo · Completed · May 28, 2026
• Anifrolumab Asian PhIII Efficacy Study for Systemic Lupus Erythematosus (SLE)
  Phase 3 · AstraZeneca · Completed · May 20, 2026
• BENLYSTA® Special Drug Use Investigation
  N/A · GlaxoSmithKline · Completed · May 18, 2026
• Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients
  Phase 2 · Novartis Pharmaceuticals · Completed · Jun 6, 2024
• Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lup
  Phase 4 · GlaxoSmithKline · Completed · Jul 23, 2025
• JBT-101 in Systemic Lupus Erythematosus (SLE)
  Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID) · Completed · Nov 18, 2022
• Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy
  Phase 2 · GlaxoSmithKline · Completed · Aug 15, 2018

Trials by condition

Lung CancerNon-Small Cell Lung CancerBreast CancerColorectal CancerGastric CancerLiver CancerPancreatic CancerProstate CancerOvarian CancerMelanomaLeukemiaLymphomaMultiple MyelomaGlioblastomaType 2 DiabetesObesityHypertensionHeart FailureAtrial FibrillationStrokeChronic Kidney DiseaseNASH / MASHAlzheimer’s DiseaseParkinson’s DiseaseMultiple SclerosisDepressionEpilepsyALSRheumatoid ArthritisPsoriasisAtopic DermatitisCrohn’s DiseaseUlcerative ColitisLupusAsthmaCOPD

All trials